FAM124B

gene
On this page

Also known as FLJ22746

Summary

FAM124B (family with sequence similarity 124 member B, HGNC:26224) is a protein-coding gene on chromosome 2q36.2, encoding Protein FAM124B (Q9H5Z6).

Located in mitochondrion and nucleoplasm.

Source: NCBI Gene 79843 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 69 total
  • MANE Select transcript: NM_001122779

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26224
Approved symbolFAM124B
Namefamily with sequence similarity 124 member B
Location2q36.2
Locus typegene with protein product
StatusApproved
AliasesFLJ22746
Ensembl geneENSG00000124019
Ensembl biotypeprotein_coding
OMIM618403
Entrez79843

Gene structure

Transcript identifiers

Ensembl transcripts: 4 — 4 protein_coding

ENST00000243806, ENST00000389874, ENST00000409685, ENST00000951903

RefSeq mRNA: 2 — MANE Select: NM_001122779 NM_001122779, NM_024785

CCDS: CCDS2461, CCDS46527

Canonical transcript exons

ENST00000409685 — 2 exons

ExonStartEnd
ENSE00001941742224401037224402107
ENSE00003515048224378698224380208

Expression profiles

Bgee: expression breadth ubiquitous, 165 present calls, max score 89.63.

FANTOM5 (CAGE): breadth broad, TPM avg 1.3054 / max 102.5033, expressed in 358 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
342340.7335278
342360.4021128
342330.105038
342350.064828

Top tissues by expression

286 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099189.63gold quality
placentaUBERON:000198774.16gold quality
superficial temporal arteryUBERON:000161472.52gold quality
subcutaneous adipose tissueUBERON:000219071.14gold quality
monocyteCL:000057669.24gold quality
mononuclear cellCL:000084269.06gold quality
leukocyteCL:000073868.99gold quality
apex of heartUBERON:000209867.90gold quality
smooth muscle tissueUBERON:000113567.52gold quality
omental fat padUBERON:001041467.49gold quality
peritoneumUBERON:000235867.42gold quality
adipose tissueUBERON:000101367.34gold quality
adipose tissue of abdominal regionUBERON:000780866.87gold quality
connective tissueUBERON:000238466.52gold quality
colonic epitheliumUBERON:000039766.09silver quality
lower lobe of lungUBERON:000894965.60silver quality
mucosa of paranasal sinusUBERON:000503064.80gold quality
visceral pleuraUBERON:000240163.75gold quality
right lungUBERON:000216763.68gold quality
tibial nerveUBERON:000132363.53gold quality
heart left ventricleUBERON:000208463.32gold quality
upper lobe of lungUBERON:000894863.22gold quality
upper lobe of left lungUBERON:000895262.97gold quality
lower esophagusUBERON:001347362.73gold quality
lower esophagus muscularis layerUBERON:003583362.71gold quality
cardiac ventricleUBERON:000208262.68gold quality
calcaneal tendonUBERON:000370162.63gold quality
gastrocnemiusUBERON:000138862.48gold quality
gall bladderUBERON:000211062.27gold quality
muscle of legUBERON:000138362.00gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-MTAB-8271yes16.44
E-ANND-3yes5.23
E-MTAB-6678no2.42

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

86 targeting FAM124B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-9-5P100.0072.282361
HSA-MIR-3646100.0073.565283
HSA-MIR-340-5P100.0072.504437
HSA-MIR-186-5P99.9970.833707
HSA-MIR-548AA99.9670.643753
HSA-MIR-548AP-3P99.9670.643753
HSA-MIR-548T-3P99.9670.643753
HSA-MIR-426799.9666.532368
HSA-MIR-4778-3P99.9370.401818
HSA-MIR-6508-5P99.9270.672465
HSA-MIR-806399.9169.763146
HSA-MIR-548E-5P99.8972.734486
HSA-MIR-806799.8669.592260
HSA-MIR-477999.8666.501583
HSA-MIR-3180-5P99.8269.122422
HSA-MIR-313399.8170.923506
HSA-MIR-4659A-3P99.8072.624248
HSA-MIR-4659B-3P99.8072.624248
HSA-MIR-3680-3P99.7572.513095
HSA-MIR-4446-5P99.7269.192544
HSA-MIR-442299.7272.072908
HSA-MIR-117999.7168.701040
HSA-MIR-33A-3P99.7070.273362
HSA-MIR-3059-5P99.7069.932491
HSA-MIR-452-5P99.6569.631762
HSA-MIR-4676-3P99.6569.311733
HSA-MIR-892C-3P99.6569.381745
HSA-MIR-497-3P99.6169.711990
HSA-MIR-24-3P99.5969.971934
HSA-MIR-1252-3P99.5567.712862

Literature-anchored findings (GeneRIF, showing 1)

  • Fam124B is a novel protein possibly involved in the pathogenesis of CHARGE syndrome and neurodevelopmental disorders. (PMID:23285124)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriofam124bENSDARG00000087489
mus_musculusFam124bENSMUSG00000043230
rattus_norvegicusFam124bENSRNOG00000054416

Paralogs (1): FAM124A (ENSG00000150510)

Protein

Protein identifiers

Protein FAM124BQ9H5Z6 (reviewed: Q9H5Z6)

All UniProt accessions (1): Q9H5Z6

UniProt curated annotations — full annotation on UniProt →

Subunit / interactions. Interacts with CHD7 and CHD8.

Subcellular location. Nucleus.

Similarity. Belongs to the FAM124 family.

Isoforms (2)

UniProt IDNamesCanonical?
Q9H5Z6-11yes
Q9H5Z6-22

RefSeq proteins (2): NP_001116251, NP_079061 (=MANE)

Domains & families (InterPro)

IDNameType
IPR029380FAM124Family
IPR046365FAM124_domDomain

Pfam: PF15067

UniProt features (10 total): sequence conflict 3, splice variant 2, chain 1, region of interest 1, compositionally biased region 1, modified residue 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9H5Z6-F163.740.30

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 49

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-9943962CHD6, CHD7, CHD8, CHD9 subfamily

MSigDB gene sets: 78 (showing top): GGTGAAG_MIR412, HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP, CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN, IL15_UP.V1_DN, IL2_UP.V1_DN, IL21_UP.V1_DN, GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_UP, LMTK3_TARGET_GENES, TFEB_TARGET_GENES, ZNF592_TARGET_GENES, ZNF766_TARGET_GENES, MIR548AA_MIR548AP_3P_MIR548T_3P, MIR186_5P, MIR497_3P, MIR4778_3P

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (3): nucleoplasm (GO:0005654), mitochondrion (GO:0005739), nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
CHD chromatin remodelers1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
intracellular membrane-bounded organelle2
binding1
nuclear lumen1
cellular anatomical structure1
cytoplasm1

Protein interactions and networks

STRING

376 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
FAM124BCHD8Q9HCK8760
FAM124BCHD7Q9P2D1571
FAM124BFAM174BQ3ZCQ3518
FAM124BOR2A2Q6IF42478
FAM124BMANEALQ5VSG8448
FAM124BSPATA13Q96N96445
FAM124BFAM167BQ9BTA0437
FAM124BFAM124AQ86V42432
FAM124BEBLN2Q6P2I7419
FAM124BZNF254O75437418
FAM124BRCN2Q14257416
FAM124BSPDYE3A6NKU9414
FAM124BHPDLQ96IR7407
FAM124BNAV1Q8NEY1404
FAM124BRPP38P78345398

IntAct

87 interactions, top by confidence:

ABTypeScore
FAM124BMDFIpsi-mi:“MI:0915”(physical association)0.710
MDFIFAM124Bpsi-mi:“MI:0915”(physical association)0.710
FAM124Bpsi-mi:“MI:0915”(physical association)0.560
KRT19FAM124Bpsi-mi:“MI:0915”(physical association)0.560
TCF4FAM124Bpsi-mi:“MI:0915”(physical association)0.560
FAM124BKRTAP5-9psi-mi:“MI:0915”(physical association)0.560
FAM124BKRTAP10-7psi-mi:“MI:0915”(physical association)0.560
FAM124BKRTAP10-9psi-mi:“MI:0915”(physical association)0.560
FAM124BTLE5psi-mi:“MI:0915”(physical association)0.560
FAM124BGOLGA2psi-mi:“MI:0915”(physical association)0.560
MKRN3FAM124Bpsi-mi:“MI:0915”(physical association)0.560
FAM124BKRT31psi-mi:“MI:0915”(physical association)0.560
KRT40FAM124Bpsi-mi:“MI:0915”(physical association)0.560
RINT1FAM124Bpsi-mi:“MI:0915”(physical association)0.560
ADAMTSL4FAM124Bpsi-mi:“MI:0915”(physical association)0.560
KCTD9FAM124Bpsi-mi:“MI:0915”(physical association)0.560
NOTCH2NLAFAM124Bpsi-mi:“MI:0915”(physical association)0.560
USHBP1FAM124Bpsi-mi:“MI:0915”(physical association)0.560
KIAA1958FAM124Bpsi-mi:“MI:0915”(physical association)0.560
FAM124BKCTD6psi-mi:“MI:0915”(physical association)0.560
FAM124BRBPMSpsi-mi:“MI:0915”(physical association)0.560
BIRC7FAM124Bpsi-mi:“MI:0915”(physical association)0.560
FAM124BLZTS2psi-mi:“MI:0915”(physical association)0.560
TRIM54FAM124Bpsi-mi:“MI:0915”(physical association)0.560
CARD9FAM124Bpsi-mi:“MI:0915”(physical association)0.560
SSX2IPFAM124Bpsi-mi:“MI:0915”(physical association)0.560

BioGRID (78): FAM124B (Two-hybrid), FAM124B (Two-hybrid), FAM124B (Two-hybrid), FAM124B (Two-hybrid), FAM124B (Two-hybrid), FAM124B (Two-hybrid), FAM124B (Two-hybrid), FAM124B (Two-hybrid), FAM124B (Two-hybrid), FAM124B (Two-hybrid), FAM124B (Two-hybrid), FAM124B (Two-hybrid), FAM124B (Two-hybrid), FAM124B (Two-hybrid), USHBP1 (Two-hybrid)

ESM2 similar proteins: A1L3T7, A2AKB4, A2RU30, A5GFW5, A6NP61, A6QLD5, A7E316, B1ASB6, P60924, Q08DK9, Q1XFL1, Q2TAK8, Q2YDQ5, Q3TD16, Q3TYX8, Q3U132, Q3U1D0, Q400C9, Q49AM3, Q571B6, Q5JXC2, Q5JYT7, Q5RA50, Q5SYB0, Q66IK8, Q6DIL6, Q6GQ34, Q6IRU7, Q6P1D7, Q6P1H6, Q6P4T1, Q7TNY7, Q7TSI1, Q7Z572, Q80XI1, Q86V42, Q8BG26, Q8BLQ0, Q8BP86, Q8BVF9

Diamond homologs: A6QLD5, Q5RA50, Q66IK8, Q6DIL6, Q6GQ34, Q86V42, Q8BLQ0, Q9H5Z6

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 33 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Keratinization615.9×1e-04

Disease & clinical

Clinical variants and AI predictions

ClinVar

69 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance61
Likely benign7
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

227 predictions. Top by Δscore:

VariantEffectΔscore
2:224380209:C:CAacceptor_loss0.9900
2:224380209:C:CCacceptor_gain0.9900
2:224401032:AATAC:Adonor_loss0.9900
2:224401033:ATAC:Adonor_loss0.9900
2:224401034:TAC:Tdonor_loss0.9900
2:224401035:AC:Adonor_loss0.9900
2:224401036:C:Adonor_loss0.9900
2:224380204:TGAAC:Tacceptor_gain0.9800
2:224380205:GAAC:Gacceptor_gain0.9800
2:224380213:A:Tacceptor_gain0.9800
2:224380207:AC:Aacceptor_gain0.9700
2:224380208:CC:Cacceptor_gain0.9700
2:224380212:C:CTacceptor_gain0.9700
2:224401063:AGT:Adonor_gain0.9600
2:224380206:AAC:Aacceptor_gain0.9500
2:224401140:TGA:Tdonor_gain0.9500
2:224380205:GAACC:Gacceptor_gain0.9400
2:224380207:ACCT:Aacceptor_gain0.9400
2:224401037:C:Gdonor_loss0.9400
2:224380206:AACCT:Aacceptor_gain0.9200
2:224380208:CCT:Cacceptor_gain0.9200
2:224380209:C:Gacceptor_gain0.9100
2:224380210:T:Aacceptor_gain0.9100
2:224400424:TGA:Tdonor_gain0.9100
2:224401138:CTTGA:Cdonor_gain0.8800
2:224401074:TGC:Tdonor_gain0.8100
2:224401152:TGCAG:Tdonor_gain0.8100
2:224401126:A:ACdonor_gain0.8000
2:224401127:C:CCdonor_gain0.8000
2:224381987:CA:Cdonor_gain0.7800

AlphaMissense

2985 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
2:224401078:A:GW231R0.996
2:224401078:A:TW231R0.996
2:224401149:A:GF207S0.996
2:224401076:C:AW231C0.995
2:224401076:C:GW231C0.995
2:224401393:A:GW126R0.995
2:224401393:A:TW126R0.995
2:224401066:C:GD235H0.992
2:224401088:G:CS227R0.990
2:224401088:G:TS227R0.990
2:224401090:T:GS227R0.990
2:224401644:A:GF42S0.990
2:224401044:A:GL242P0.989
2:224401065:T:AD235V0.989
2:224401077:C:GW231S0.989
2:224401148:A:CF207L0.989
2:224401148:A:TF207L0.989
2:224401150:A:GF207L0.989
2:224401489:A:GW94R0.989
2:224401489:A:TW94R0.989
2:224401064:G:CD235E0.988
2:224401064:G:TD235E0.988
2:224401487:C:AW94C0.988
2:224401487:C:GW94C0.988
2:224401065:T:GD235A0.987
2:224401113:A:GL219P0.986
2:224401305:A:GL155P0.986
2:224401315:C:GA152P0.986
2:224401041:A:GL243P0.985
2:224401728:A:GL14P0.985

dbSNP variants (sampled 300 via entrez): RS1000206890 (2:224386226 G>A,T), RS1000364115 (2:224403965 AAC>A), RS1000451886 (2:224397761 T>C), RS1000568038 (2:224398030 T>A), RS1000648527 (2:224387404 C>G), RS1000669880 (2:224393682 G>C), RS1000928779 (2:224380778 C>A), RS1000941498 (2:224387646 C>T), RS1001065849 (2:224393453 G>A), RS1001139021 (2:224402890 C>A,T), RS1001233131 (2:224401341 T>TAC), RS1001504303 (2:224391576 T>G), RS1001556623 (2:224391933 C>T), RS1001836698 (2:224393061 A>G), RS1001951145 (2:224392721 C>A,T)

Disease associations

OMIM: gene MIM:618403 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST006088_63Familial squamous cell lung carcinoma8.000000e-06
GCST008521_11Bitter beverage consumption2.000000e-06
GCST008524_13Bitter non-alcoholic beverage consumption5.000000e-07

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0006953family history of lung cancer
EFO:0010089bitter beverage consumption measurement
EFO:0010093bitter non-alcoholic beverage consumption measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

11 total (human), top 11 by PubMed support.

ChemicalActions (top 5)PubMed papers
S-(1,2-dichlorovinyl)cysteineincreases expression, affects response to substance1
Air Pollutantsaffects methylation, increases abundance1
Benzo(a)pyreneincreases methylation, decreases methylation1
Latexincreases expression1
Lipopolysaccharidesdecreases expression, affects response to substance, increases expression1
Nitrogen Dioxideaffects methylation, increases abundance1
Thimerosaldecreases expression1
Aflatoxin B1increases methylation1
Asbestos, Serpentineincreases expression1
Copper Sulfatedecreases expression1
Particulate Matteraffects methylation, increases abundance1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.